NO175214C - - Google Patents

Info

Publication number
NO175214C
NO175214C NO862100A NO862100A NO175214C NO 175214 C NO175214 C NO 175214C NO 862100 A NO862100 A NO 862100A NO 862100 A NO862100 A NO 862100A NO 175214 C NO175214 C NO 175214C
Authority
NO
Norway
Prior art keywords
enzyme
alpha
glycine
purified
peptidyl
Prior art date
Application number
NO862100A
Other languages
English (en)
Norwegian (no)
Other versions
NO862100L (no
NO175214B (de
Inventor
James P Gilligan
Barry N Jones
Original Assignee
Unigene Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24628603&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO175214(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Unigene Lab Inc filed Critical Unigene Lab Inc
Publication of NO862100L publication Critical patent/NO862100L/no
Publication of NO175214B publication Critical patent/NO175214B/no
Publication of NO175214C publication Critical patent/NO175214C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y114/00Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/17Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with reduced ascorbate as one donor, and incorporation of one atom of oxygen (1.14.17)
    • C12Y114/17003Peptidylglycine monooxygenase (1.14.17.3)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO86862100A 1984-09-27 1986-05-27 Alfa-amideringsenzym. NO862100L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/655,366 US4708934A (en) 1984-09-27 1984-09-27 α-amidation enzyme
PCT/US1985/001616 WO1986002099A1 (en) 1984-09-27 1985-08-26 Alpha-amidation enzyme

Publications (3)

Publication Number Publication Date
NO862100L NO862100L (no) 1986-05-27
NO175214B NO175214B (de) 1994-06-06
NO175214C true NO175214C (de) 1994-09-14

Family

ID=24628603

Family Applications (1)

Application Number Title Priority Date Filing Date
NO86862100A NO862100L (no) 1984-09-27 1986-05-27 Alfa-amideringsenzym.

Country Status (13)

Country Link
US (1) US4708934A (de)
EP (1) EP0201511B1 (de)
JP (1) JP2594037B2 (de)
AT (1) ATE92522T1 (de)
CA (1) CA1341037C (de)
DE (1) DE3587506T2 (de)
DK (1) DK241486D0 (de)
FI (1) FI100993B1 (de)
HU (1) HU195857B (de)
LT (1) LT2661B (de)
NO (1) NO862100L (de)
RU (1) RU1802814C (de)
WO (1) WO1986002099A1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319685B1 (en) * 1984-09-27 2001-11-20 Unigene Laboratories, Inc. Alpha-amidating enzyme compositions and processes for their production and use
DE3612302A1 (de) * 1986-04-11 1987-10-15 Hoechst Ag Chromophore peptide, verfahren zu ihrer herstellung und ihre verwendung zum nachweis der peptidylglycin-(alpha)-amidierenden monooxygenase
JPH0775541B2 (ja) * 1986-06-07 1995-08-16 壽之 松尾 C末端アミド化酵素及びその製造方法
JP2598050B2 (ja) * 1987-07-17 1997-04-09 サントリー株式会社 C−末端α−アミド化酵素
US5821083A (en) * 1987-07-17 1998-10-13 Suntory Limited Recombinant C-terminal α-amidating enzyme
US5789234A (en) * 1987-08-14 1998-08-04 Unigene Laboratories, Inc. Expression systems for amidating enzyme
US6255067B1 (en) * 1987-09-15 2001-07-03 The Johns Hopkins University cDNA encoding peptidyl-glycine alpha-amidating monooxygenase (PAM)
JP2653820B2 (ja) * 1988-03-14 1997-09-17 壽之 松尾 アミド化酵素及びその製造方法
DE68917154T2 (de) * 1988-05-30 1994-12-22 Shiseido Co Ltd C-terminus-amidierungsenzym-zusammensetzung, verfahren zur herstellung und verwendung.
JP2512575B2 (ja) * 1988-05-30 1996-07-03 株式会社資生堂 C末端アミド化酵素組成物、調製方法および使用
JP2845468B2 (ja) * 1989-01-17 1999-01-13 サントリー株式会社 ヒト甲状腺由来C―末端α―アミド化酵素
US5871995A (en) * 1989-08-15 1999-02-16 Shiseido Company, Ltd. Purified enzymes participating in C-terminal amidation
EP0448513A3 (en) * 1990-03-21 1991-12-27 Japat Ltd Process for production of peptidylglycine alpha-hydroxylating monooxygenase and use thereof
US5580751A (en) * 1990-09-14 1996-12-03 Carlsberg A/S Process for the preparation of C-terminally amidated peptides
DK220890D0 (da) * 1990-09-14 1990-09-14 Ole Buchardt Fremgangsmaade til fremstilling af c-terminalt amiderede peptider
JP2774769B2 (ja) * 1993-04-26 1998-07-09 賢治 寒川 アドレノメデュリン
WO1997013410A1 (en) * 1995-10-13 1997-04-17 Boston Medical Center Corporation Hybrid molecules containing amidated polypeptide binding ligands
US5912014A (en) * 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
AU742270B2 (en) 1997-04-16 2001-12-20 Enteris Biopharma, Inc. Direct expression of peptides into culture media
US6507788B1 (en) 1999-02-25 2003-01-14 Société de Conseils de Recherches et D'Applications Scientifiques (S.C.R.A.S.) Rational selection of putative peptides from identified nucleotide, or peptide sequences, of unknown function
US8088734B2 (en) 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
US7445911B2 (en) * 2004-11-24 2008-11-04 Unigene Laboratories Inc. Enzymatic reactions in the presence of keto acids
DE102004058306A1 (de) * 2004-12-01 2006-07-27 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung von Carboxy-terminal amidierten Peptiden
PA8660701A1 (es) 2005-02-04 2006-09-22 Pfizer Prod Inc Agonistas de pyy y sus usos
EP1907561B1 (de) * 2005-06-24 2013-08-28 Unigene Laboratories, Inc. Zellinien zur expression eines bei der herstellung amidierter produkte geeigneten enzyms
US8377863B2 (en) 2007-05-29 2013-02-19 Unigene Laboratories Inc. Peptide pharmaceutical for oral delivery
EP2172550B1 (de) * 2007-06-29 2014-08-06 Daiichi Sankyo Company, Limited C-TERMINAL-alpha-AMIDIERTES REKOMBINANTES ENZYMDERIVAT
ES2622877T3 (es) * 2009-01-22 2017-07-07 Keybioscience Ag Tratamiento para la obesidad
WO2011067283A1 (en) 2009-12-01 2011-06-09 Novo Nordisk A/S Novel peptidyl alpha-hydroxyglycine alpha-amidating lyases
TW201138808A (en) 2010-05-03 2011-11-16 Bristol Myers Squibb Co Serum albumin binding molecules
ES2712805T3 (es) 2011-06-15 2019-05-14 Resother Pharma Aps Næsseslottet Productos farmacéuticos antiinflamatorios
US9533022B2 (en) 2011-11-02 2017-01-03 KeyBioscience A/S Peptide analogs for treating diseases and disorders
JP6170933B2 (ja) 2011-11-02 2017-07-26 キーバイオサイエンス・アクチエンゲゼルシャフト ペプチドの使用
HUE039105T2 (hu) 2011-11-02 2018-12-28 Keybioscience Ag Kalcitonin mimetikumok betegségek és rendellenességek kezelésére
DK3068796T3 (en) 2013-11-14 2018-03-05 Keybioscience Ag CALCITONIN MIMETICS FOR THE TREATMENT OF DISEASES AND DISORDERS
WO2015084875A1 (en) 2013-12-02 2015-06-11 Stealth Peptides International, Inc. Compositions and methods for treating vitiligo
US10576124B2 (en) 2014-05-28 2020-03-03 Stealth Biotherapeutics Corp Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
WO2015183988A1 (en) 2014-05-28 2015-12-03 Stealth Peptides International, Inc. Therapeutic compositions including therapeutic small molecules and uses thereof
US10627392B2 (en) 2014-06-17 2020-04-21 Stealth Biotherapeutics Corp Methods of identifying and monitoring mitochondrial dysfunction using monocyte screening
GB201500263D0 (en) 2015-01-08 2015-02-25 Keybioscience Ag Calcitonin analogues for treating diseases and disorders
US9833411B2 (en) 2015-01-12 2017-12-05 Enteris Biopharma, Inc. Solid oral dosage forms
WO2016130899A1 (en) 2015-02-13 2016-08-18 The Board Of Trustees Of The University Of Illinois Peptide inhibition of ccr3-mediated diseases or conditions
GB201704429D0 (en) 2017-03-21 2017-05-03 Keybioscience Ag Calcitonin mimetics for treating diseases and disorders
GB201707955D0 (en) 2017-05-18 2017-07-05 Keybioscience Ag Dual amylin and calcitonin receptor agonists for treating diseases and disorders
GB201813677D0 (en) 2018-08-22 2018-10-03 Keybioscience Ag Calcitonin mimetics for treating diseases and disorders
GB201813678D0 (en) 2018-08-22 2018-10-03 Keybioscience Ag Acylated calcitonin mimetics
JP2022543056A (ja) 2019-07-29 2022-10-07 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイ 創傷治癒を促進するための組成物および方法
GB202001024D0 (en) 2020-01-24 2020-03-11 Key Bioscience Ag Oxyntomodulin mimetics

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319685B1 (en) * 1984-09-27 2001-11-20 Unigene Laboratories, Inc. Alpha-amidating enzyme compositions and processes for their production and use

Also Published As

Publication number Publication date
FI94361C (fi) 1995-08-25
LT2661B (lt) 1994-04-25
JPS62500560A (ja) 1987-03-12
AU594026B2 (en) 1990-03-01
FI862216A0 (fi) 1986-05-26
DK241486A (da) 1986-05-23
EP0201511A1 (de) 1986-11-20
WO1986002099A1 (en) 1986-04-10
FI862216A (fi) 1986-05-26
DE3587506D1 (en) 1993-09-09
NO862100L (no) 1986-05-27
FI100993B1 (fi) 1998-03-31
JP2594037B2 (ja) 1997-03-26
FI94361B (fi) 1995-05-15
DK241486D0 (da) 1986-05-23
AU4802785A (en) 1986-04-17
EP0201511B1 (de) 1993-08-04
CA1341037C (en) 2000-06-27
HU195857B (en) 1988-07-28
EP0201511A4 (de) 1988-05-31
US4708934A (en) 1987-11-24
HUT41444A (en) 1987-04-28
NO175214B (de) 1994-06-06
DE3587506T2 (de) 1994-01-13
RU1802814C (ru) 1993-03-15
ATE92522T1 (de) 1993-08-15

Similar Documents

Publication Publication Date Title
DE3587506D1 (en) Alpha-amidierungsenzym.
EP1674565A3 (de) Verfahren zur Erhöhung der Enzym-Aktivität bei erhöhter Temperatur
ES8501629A1 (es) Procedimiento para producir t-p-a humano activador de plasminogeno.
MY103189A (en) Nor-statine and nor-cyclostatine polypeptides
Briand et al. Investigation of the requirements for O-glycosylation by bovine submaxillary gland UDP-N-acetylgalactosamine: polypeptide N-acetylgalactosamine transferase using synthetic peptide substrates.
IE890873L (en) Biologically Active Material Characterised by Catabolic Activity Generally Associated with Cachexia Inducing Tumours, Preparations, Production and Uses Thereof
Wong et al. The architecture of the animal fatty acid synthetase. III. Isolation and characterization of beta-ketoacyl reductase.
Pouluse et al. Primary structure of a chymotryptic peptide containing the “active serine” of the thioesterase domain of fatty acid synthase
Reddy et al. Identification of a new glutathione S-transferase from rat liver cytosol
Tanaka et al. The primary structure of bovine adrenodoxin
NO961031D0 (no) Fremgangsmåte til å drepe uönskede målceller
GR3015924T3 (en) Catabolic enzymes for the induction of the tumour necrosis factor (TNF).
ES2003180A6 (es) Un metodo para preparar un polipeptido capaz de modular la actividad del crecimiento.
FR2644894B1 (fr) Trousse et methode de dosage enzymatique applicables a des cellules entieres
CA2078861A1 (en) Total gonadotropal alpha peptide chain assay
EP0354652A3 (de) Alpha-N-Acetylgalactosaminyltransferase und ihre Verwendung zum Nachweis von Tumorzellen
ES8707796A1 (es) Metodo para la cuantificacion del antigeno procoagulante delcancer en una muestra biologica
GB2229725B (en) A method of enhancing neutralising antibody activity in human or animal sera or in other body secreations
DE3881321T2 (de) Octapeptide als Hemmer myristoylierender Enzyme.
CS435588A1 (en) Method of biosensors preparation on base of immobilized enzymes,cells and their fragments
JPS5529985A (en) Reagent for determining guanase

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN FEBRUARY 2003